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Abstract The role of myosin-binding in cytoskeletal arrange-
ment of non-muscle low molecular weight caldesmon (l-
caldesmon) was studied. The N-terminal myosin-binding domain
of caldesmon (N152) colocalized with myosin in transiently
transfected chicken fibroblasts. When added exogenously to the
Triton-insoluble cytoskeleton, N152 enhanced l-caldesmon dis-
placement by exogenous C-terminal actin-binding fragment
(H1). Thus, a significant fraction of l-caldesmon cross-links
actin and myosin. In contrast, in epithelioid HeLa cells most of
l-caldesmon was only actin-bound as H1 alone was enough for its
displacement. Phosphorylation by mitogen-activated protein
kinase reduced the capability of H1 to displace endogenous
l-caldesmon, suggesting it may represent a regulatory mechanism
for actin^caldesmon interaction in vivo. ß 2001 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Interaction between actin and myosin underlies a wide va-
riety of intracellular motile events including contractility, sub-
strate attachment, shape changes, intracellular granule move-
ment and division. Both structural and functional means exist
to control the accessibility of actin by myosin motor domain
in smooth and non-muscle cells. The spatial requirement for
actomyosin assembly is often achieved through rearrangement
of actin cytoskeleton guided by small GTP-binding proteins of
the Rho family [1], while functional regulation is mediated by
a speci¢c Ca2/calmodulin-dependent phosphorylation of my-
osin regulatory light chains [2] and actin ¢lament-associated
protein caldesmon [3].
Caldesmon is a multifunctional actin-binding protein that
inhibits actomyosin interaction and ATPase activity by pre-
venting the strong binding of myosin heads to actin in a Ca2/
calmodulin- and tropomyosin-dependent manner (reviewed in
[3]). The inhibitory activity of caldesmon and the high a⁄nity
binding sites for calmodulin, actin and tropomyosin reside in
the C-terminal part of the molecule, whereas the N-terminal
region contains tropomyosin-binding and the major myosin-
binding site of the protein [4^6]. Two isoforms of caldesmon
identi¢ed in smooth muscle and non-muscle cells di¡er in an
extended central spacer domain which links structurally and
functionally conserved termini, implying that both high
(h-caldesmon) and low molecular weight (l-caldesmon) iso-
forms have matching functions in vivo [7]. While the func-
tional activity of caldesmon has been well documented in
both ATPase assays [8,9], in vitro motility studies [4,10,11]
and skinned or intact muscle ¢ber models [12^14], less evi-
dence is available for the involvement of l-caldesmon in struc-
tural aspects of cytoskeleton dynamics and architecture.
In non-muscle cells l-caldesmon was localized to actin stress
¢bers [15^17], membrane ru¥es [16] and lamellipodia exten-
sions [17]. It was implicated in glucocorticoid-induced actin
reorganization [18], association with signaling receptor com-
plexes [19,20], vesicular transport [21], and mitosis-speci¢c
regulation of actin dynamics [22]. Transfection of cultured
non-muscle cells with the full-length caldesmon cDNA re-
sulted in either altered cell morphology and increased cell
spreading [23], or decreased contractility, inhibition of stress
¢ber formation and focal adhesions [17]. Overexpression of
the fully functional actin-binding C-terminal fragment of cal-
desmon also promoted cell spreading, but has been reported
to inhibit attachment and to stabilize actin bundles and tro-
pomyosin with no e¡ect on actin dynamics and intracellular
granule movement [24,25]. Hence, it is likely that the N-ter-
minal myosin-binding activity of the full-length caldesmon
adds signi¢cantly to the structural function of caldesmon.
The structural aspect of caldesmon function is thought to
involve ‘tethering’ actin to myosin ¢laments. The cross-linking
activity of caldesmon has been described in vitro [5,26] and in
in vitro motility studies [4,11]. In permeabilized smooth
muscle cells and platelets the N-terminal caldesmon fragments
or peptides had dissociating e¡ects on actomyosin and af-
fected contraction [27,28], suggestive of a role for N-terminal
myosin-binding of caldesmon in ‘tethering’ actomyosin in liv-
ing cells. Furthermore, caldesmon is thought to be regulated
by phosphorylation in smooth muscle ([29] for a review) and
non-muscle cells [22]. The major caldesmon kinase in vivo has
been identi¢ed as p42/44erk1;2 mitogen-activated protein kinase
(MAP-kinase) which phosphorylates sites in the C-terminus of
caldesmon [30]. While the e¡ect of MAP-kinase on caldesmon
inhibitory activity is still questionable, evidence is growing
that phosphorylation alters caldesmon interaction with actin
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in vitro [31^33]. In this report we further address the two
questions as to whether caldesmon cross-links actomyosin
and if phosphorylation regulates this activity in native cyto-
skeleton of non-muscle cells.
In order to assess the arrangement of l-caldesmon in cyto-
skeleton of permeabilized cells we used the recombinant C-
terminal (H1) and N-terminal (N152) caldesmon fragments to
antagonize interaction of endogenous caldesmon with actin
and myosin, respectively. First, we show that N152 colocalizes
with myosin ¢laments in transiently transfected chicken ¢bro-
blasts thus demonstrating functionality of the isolated N-ter-
minal myosin-binding site in vivo. Second, we ¢nd that in
these cells a signi¢cant fraction of l-caldesmon simultaneously
binds and cross-links actin and myosin as it could only be
displaced by both H1 and N152, while the rest of l-caldesmon
appears to be only micro¢lament-associated. In contrast, in
HeLa cells most of l-caldesmon is bound to the actin cyto-
skeleton and could be displaced by H1 alone. Third, we dem-
onstrate that phosphorylation of H1 by MAP-kinase de-
creased its displacing ability thus implicating the MAP-
kinase in regulation of cytoskeletal dynamics and architecture
via the e¡ect on actin-binding and cross-linking properties of
caldesmon.
2. Materials and methods
2.1. Expression and transfection of caldesmon constructs
The cDNA encoding the N-terminal 152 residues of chicken gizzard
caldesmon (N152 fragment) was subcloned from the pMWT172-N152
plasmid [5] into pcDNA3 vector (Invitrogen) using the BamHI and
EcoRI restriction sites. Then it was subcloned into pFLAG CMV2
vector (Kodak) using the HindIII and EcoRI restriction sites to en-
code N152 with the N-terminal FLAG sequence followed by an arti-
¢cial Leu-Gly-Thr-Gln-Leu-Gly-Ser sequence as a result of subclon-
ing. Chicken ¢broblasts at 50^70% con£uence were transfected using
the Maxifectin-21 kit (Pepline, Moscow, Russia) according to the
manufacturer’s protocol and after 12 h of incubation were processed
for immuno£uorescence. N152 and the C-terminal caldesmon frag-
ment H1 were expressed in BL21(DE3)pLys Escherichia coli cells
transformed with pMWT172-N152 and pMWT172-H1 plasmids as
earlier [5,32]. H1 phosphorylated by recombinant GST-p44erk1
MAP-kinase was obtained as described in [32] with modi¢cations [33].
2.2. Cell isolation, culturing and immuno£uorescence
Chicken ¢broblasts (obtained by passaging the primary chicken
embryo gizzard cells) and HeLa cells (ATCC# CCL-2) were cultured
in DMEM (Sigma) supplemented with 10% fetal calf serum, 2 mM
L-glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin (all from
HyClone). For immuno£uorescence microscopy, ¢broblasts were ¢xed
in 3.7% formaldehyde and permeabilized with 1% Triton X-100.
FLAG-tagged N152 was visualized with mouse monoclonal antibody
to FLAG (Kodak). An anti-chicken gizzard myosin polyclonal anti-
body was raised in rabbits and subsequently a⁄nity-puri¢ed. This
antibody speci¢cally cross-reacted with non-muscle (Fig. 1B) and
smooth muscle myosin. FITC-labeled goat anti-mouse (Molecular
Probes) and Texas red-labeled anti-rabbit secondary (Sigma) antibod-
ies were used. Cells were examined using Zeiss Photomicroscope III
and photographed on Kodak Tri X-pan 400 ¢lm.
2.3. Caldesmon displacement analysis
Cells were grown in six-well plates until 80^90% con£uence and
washed twice with ice-cold phosphate-bu¡ered saline. Cells were per-
meabilized for 15 min on ice with 10 mM Tris^HCl, pH 7.0, 60 mM
KCl, 125 mM sucrose, 0.05% Triton X-100, 0.1 mM EGTA, 5 mM
MgCl2, 1 mM dithiothreitol, 0.05 mM phenylmethylsulfonyl£uoride,
and washed twice with the binding bu¡er containing 10 mM Tris^
HCl, pH 7.0, 30 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol and
0.05 mM phenylmethylsulfonyl£uoride to obtain the Triton-insoluble
cytoskeletons. 1 ml of the binding bu¡er containing appropriate con-
centrations of caldesmon fragments was then added to each well.
After incubation on ice for 15 min the cytoskeletons were washed
twice with the binding bu¡er and extracted with 2U concentrated
loading bu¡er for sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE). The proteins were resolved by SDS^PAGE in
duplicates and transferred onto nitrocellulose membranes (Bio-Rad).
The membranes were treated with 0.25% glutaraldehyde for 30 min
and probed with rabbit anti-chicken gizzard caldesmon primary anti-
body [32] to detect l-caldesmon and H1 or with the fraction of this
antibody puri¢ed on immobilized N152 to detect the N-terminal cal-
desmon fragment. Secondary peroxidase-conjugated anti-rabbit anti-
body (Pierce) was used and the membranes were developed with 3,3P-
diaminobenzidine. HP-IIcx scanner and NIH Image software were
used to quantify immunoblots.
3. Results
3.1. The N-terminal domain of caldesmon colocalizes with
myosin in transfected cells
To investigate whether the N-terminal myosin-binding ac-
tivity of caldesmon is functional in living cells, chicken ¢bro-
blasts were transfected with pFLAG CMV2 expression vector
containing inserted cDNA encoding the N152 caldesmon frag-
ment. Fig. 1 shows that N152 colocalized with the myosin-
containing ¢lamentous structures as revealed by double im-
muno£uorescence using anti-FLAG M2 antibody and anti-
myosin antibody that speci¢cally recognizes non-muscle my-
osin on Western blot (Fig. 1C). In addition, the nuclear stain-
ing of N152-FLAG was also observed in the transfected cells,
consistent with the earlier reported ability of low molecular
weight proteins to penetrate into this cellular compartment
[34]. Transfection of ¢broblasts with the control pFLAG-
BAP plasmid (Kodak) resulted in homogeneous cytoplasmic
distribution of BAP (data not shown) indicating speci¢c intra-
cellular localization of N152. This and our previous data [5]
indicate that the N-terminal domain of caldesmon contains a
myosin-binding sequence, which is fully functional in the cel-
lular context and thus may mediate the caldesmon^myosin
interaction.
3.2. Caldesmon cross-links actin and myosin in chicken
¢broblasts, but not in HeLa cells
Chicken gizzard ¢broblasts and epithelioid HeLa cells were
used to assess distribution of endogenous l-caldesmon within
the naturally arranged cytoskeleton. The cultured cells were
permeabilized with Triton X-100 to preserve cytoskeleton and
the displacement of endogenous l-caldesmon from the Triton-
insoluble cytoskeletal fraction by added bacterially expressed
caldesmon fragments was investigated. As shown in Figs. 2
and 3, addition of increasing amounts of N152 alone caused
no displacement of l-caldesmon indicating that l-caldesmon
did not only bind to myosin. No displacement was also ob-
served when as much as 50 WM N152 alone was applied (data
not shown). Incubation of ¢broblast cytoskeletons with in-
creasing concentrations of the C-terminal actin-binding frag-
ment H1 caused as little as 20% of endogenous l-caldesmon
displacement suggesting it represents only the actin-bound
fraction (Fig. 2). However, titration with H1 in the presence
of N152 caused up to 60% dissociation of l-caldesmon (Fig.
2). This suggests that at least 40% of the endogenous caldes-
mon is simultaneously bound to actin and myosin ¢laments
and cross-links them in ¢broblast cytoskeleton.
In contrast, H1 alone was su⁄cient to dissociate most of
the endogenous l-caldesmon from Triton-insoluble cytoskele-
ton of HeLa cells (Fig. 3). Moreover, concomitant addition of
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N152 produced little further e¡ect on l-caldesmon displace-
ment despite very high sequence homology between the N-
terminal domains of chicken and mammalian caldesmons.
Thus, most of caldesmon appears to be only actin-bound in
epithelioid HeLa cells.
3.3. Phosphorylation by MAP-kinase inhibits actin^caldesmon
interaction
Phosphorylation by MAP-kinase has been reported to af-
fect the actin-binding a⁄nity of caldesmon in vitro [31^33].
Here we further studied whether this e¡ect is conserved in
naturally arranged cytoskeleton. For this purpose, the C-ter-
minal caldesmon fragment H1 was phosphorylated in vitro by
active recombinant p44erk1 MAP-kinase. Two serines corre-
sponding to residues 759 and 789 of the human h-caldesmon
sequence were found to be fully phosphorylated (Levine, B.A.,
Marston, S.B. and Vorotnikov, A.V., unpublished observa-
tion). The phosphorylated H1 was found much less e¡ective
in displacement of endogenous l-caldesmon from HeLa cyto-
skeleton than its unphosphorylated counterpart (Fig. 3). This
illustrates that phosphorylation inhibits interaction of H1 with
actin cytoskeleton per se and implies that MAP-kinase regu-
lates actin^caldesmon interaction in cells.
4. Discussion
The mechanism by which caldesmon cross-links actin to
myosin has been addressed in multiple studies in vitro and
¢nally has been shown to involve simultaneous binding of
its C-terminal part to actin and interaction of the N-terminus
with myosin subfragment 2 [5]. However, the arrangement of
caldesmon inside living cells has been a matter of long debate
because it is impossible to visualize it within the dense acto-
myosin domain. Indirect evidence indicates that an impair-
ment of caldesmon interaction with cytoskeletal proteins per
se, such as microinjection of antibody interfering with tropo-
myosin binding [35], endogenous caldesmon phosphorylation
that inhibited its actin-binding [22], treatment of permeabil-
ized cells with the N-terminal myosin-binding fragment [27]
or synthetic peptides [28], causes partial displacement of en-
dogenous caldesmon and results in changes of cell morphol-
ogy, disruption of cytoskeleton, or modulation of contractil-
ity. For most of these e¡ects the dissociation of caldesmon-
mediated cross-link and loss of ‘tethering’ actin to myosin
¢laments have been implied, albeit structural evidence has still
been missing.
In this report we used a transfection technique and directly
demonstrated that the N-terminal domain of caldesmon inter-
acts with myosin in intact cytoskeleton. These results agree
with the recent observation that myosin-binding peptides of
the N-terminus of caldesmon label actomyosin-like structures
within the contractile domain of permeabilized ferret smooth
muscle cells [28] and thus justify the potential use of N152 to
dissociate endogenous caldesmon from myosin ¢laments in
permeabilized cells.
Direct evidence is now provided that a signi¢cant fraction
of l-caldesmon is involved in cross-linking of actomyosin in
¢broblast cytoskeleton. This correlates with the high degree of
Fig. 1. Colocalization of the N-terminal caldesmon fragment with myosin in chicken ¢broblasts. The cells were transiently transfected with
pFLAG CMV2 vector bearing the insert encoding the N-terminal myosin-binding domain of caldesmon N152 and immunostained either
against myosin (A) or FLAG tag (B). C shows that the anti-myosin antibody recognizes only myosin heavy chains (MHC) on the Western blot
(lane 2) of total ¢broblast protein (lane 1).
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actin and myosin colocalization in these cells as revealed by
immuno£uorescent microscopy and their prominent motile
activity. On the other hand, our results on l-caldesmon dis-
placement from HeLa cytoskeletons do not reveal myosin-
bound caldesmon. Perhaps, the fraction of juxtapositioned
actin and myosin ¢laments in these cells is smaller than in
¢broblasts due to the peculiarities of epithelioid cell cytoskel-
eton organization and the relatively low level of actomyosin
found in many transformed cells.
The ¢nding that caldesmon signi¢cantly contributes to
‘tethering’ actin to myosin in permeabilized cells suggests
that it may be directly involved in modulation of cytoskeletal
dynamics during such events as cell motility, chemotaxis and
cytokinesis. Reversible phosphorylation of actin-associated
proteins may constitute a mechanism for modulating their
activity and lead to changes in cytoskeletal dynamics. We
hypothesized that caldesmon is similarly regulated. The bind-
ing of caldesmon to myosin is a¡ected by phosphorylation
within its N-terminal domain in vitro, however, the responsi-
ble kinases are unlikely to phosphorylate caldesmon in vivo
(reviewed in [29]). Only p42/44erk1;2 MAP-kinase and protein
kinase C were shown to phosphorylate sites within the
C-terminal actin-binding domain of caldesmon in intact
smooth muscle [30,32] and non-muscle cells [36,37], respec-
tively. Both inhibit actin^caldesmon interaction in vitro [29]
Fig. 3. Displacement of l-caldesmon from Triton-insoluble cytoskele-
tons of HeLa cells by exogenous caldesmon fragments and the e¡ect
of MAP-kinase phosphorylation. Abbreviations are as in the legend
for Fig. 2, P-H1 (squares) denotes H1 phosphorylated in vitro by
the recombinant p44erk1 MAP-kinase. A: Quanti¢cation of immuno-
blots represented in (B), the mean values þ S.E.M. from two deter-
minations for 5 WM N152 alone and four independent experiments
otherwise are shown.
Fig. 2. Dissociation of caldesmon from Triton-insoluble cytoskele-
tons of chicken ¢broblasts. A: The displacement of l-caldesmon iso-
form by increasing amounts of exogenously added actin-binding
(H1, open circles), myosin-binding (N152, triangles) recombinant
fragments of caldesmon, or by increasing H1 in the constant pres-
ence of 50 WM N152 (H1+N152, closed circles) is shown. Each
point is the mean þ S.E.M. from two determinations for 2.5 WM
N152 alone and four independent experiments otherwise. B: Repre-
sentative immunoblots showing l-caldesmon (l-CaD) content left in
Triton-insoluble cytoskeletons of ¢broblasts incubated with exoge-
nous caldesmon fragments depicted on the right (a) and relative
binding of these fragments to cytoskeletons (b). The applied concen-
trations of individual caldesmon fragments are indicated below,
H1+50 WM N152 denotes indicated concentrations of H1 in the
constant presence of 50 WM N152. The actin band staining and
quanti¢cation (not shown) con¢rmed equal loading onto the gels.
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while no signi¢cant e¡ect of MAP-kinase on other caldesmon
activities has been described so far [32,38^40]. This report
con¢rms the in vitro results that phosphorylation by MAP-
kinase inhibits caldesmon interaction with isolated actin ¢la-
ments [31,33] and provides the ¢rst indication that this e¡ect
is conserved in the native Triton-insoluble cytoskeleton sug-
gesting it can serve as a major function of caldesmon phos-
phorylation in vivo.
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